RaySearch Laboratories AB (publ) has received a new RayStation®* order to support advanced proton therapy at Stanford Health Care. The order adds tools for advanced proton arc therapy, including support for upright treatments.
Building on the initial adoption of RayStation® for treatment planning on Accuray CyberKnife® systems in the second quarter of 2024, the new licenses will enable the use of RayStation with the newly FDA-cleared Mevion FIT® system for proton therapy at Stanford Health Care.
Mevion FIT is a fully integrated system combining Mevion’s proton therapy beam delivery with Leo Cancer Care’s patient positioning and imaging systems, forming a compact solution for proton therapy. RaySearch has long-standing collaborations with both Leo Cancer Care and Mevion, and continuously adapts RayStation to support the latest innovations from both companies.
Johan Löf, founder and CEO, RaySearch, comments: “Innovation happens when hardware, software, and clinical expertise come together. Our collaboration with Stanford Health Care, Mevion, and Leo Cancer Care is a strong example of this—bringing together leading technologies and clinicians to shape the future of cancer treatment.”
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB
Telephone: +46 (0) 8 510 530 00
Carolina Strömlid, Head of Investor Relations, RaySearch Laboratories AB
Telephone: +46 (0) 708 807 173
ir@raysearchlabs.com
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch’s software has been sold to over 1,100 clinics in 47 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.
About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
* Subject to regulatory clearance in some markets.